St. Jude Children’s Research Hospital is one of the world’s premier research and treatment centers for childhood cancer. With unique clinical trials, innovative science and comprehensive patient care, our physicians and researchers are defining new frontiers in pediatric oncology.
Treatment Information
Meet Our Patients
We treat the toughest cases.
-
Spurred into Action: Discovering the Origins of Rhabdomyosarcoma
In the race to increase survival rates for the soft-tissue cancer, one researcher proved rhabdomyosarcoma can originate in the inner surface of blood vessels.
-
Medulloblastoma: DNA Points the Way
Find out about how the discovery of 6 inherited gene mutations in medulloblastoma prompted the proposed guidelines for genetic counseling and testing when treating this type of brain cancer.
-
Taking Aim at AML: The Mission Continues
Protein profiling may identify moving treatments targets for acute myeloid leukemia. Find out how researchers team up in the VENAML clinical trial to reduce cancer development.
-
SJFAMILY: Shaking the Family Tree
Through the SJFAMILY study, St. Jude investigators explore why some cancers run in families and why certain people get more than one cancer.
-
An Unwavering Partner in Pain Care
The St. Jude Pain Management Service is dedicated to easing the discomfort and distress of illness and treatments.
-
Six More Reasons to Love St. Jude
Patients and families often praise St. Jude clinical care and research. Find out why they have even more reasons to love the hospital.
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
St. Jude Cloud
St. Jude Cloud offers the world's largest public repository of pediatric cancer genomics data alongside unique analysis and visualization tools.
Innovative Clinical Trials
St. Jude develops more oncology clinical trials than any other U.S. children's hospital. Armed with leading-edge research, superb resources, and a strongly collaborative culture, we translate laboratory discoveries into new options for children with tough-to-treat cancers.
Pediatric Cancer Genome Project
The roots of pediatric cancer are hidden deep within a child’s DNA. The St. Jude—Washington University Pediatric Cancer Genome Project is the world’s most ambitious effort to discover the origins of childhood cancer and seek new cures.
Cancer Survivorship Research
Improved treatments for childhood cancer have helped swell the ranks of survivors to more than 425,000 individuals nationwide. St. Jude is pioneering the field of cancer survivorship with major research programs that follow thousands of survivors for decades after their treatment.
Latest Oncology Research
-
Spurred into Action: Discovering the Origins of Rhabdomyosarcoma
In the race to increase survival rates for the soft-tissue cancer, one researcher proved rhabdomyosarcoma can originate in the inner surface of blood vessels.
-
Medulloblastoma: DNA Points the Way
Find out about how the discovery of 6 inherited gene mutations in medulloblastoma prompted the proposed guidelines for genetic counseling and testing when treating this type of brain cancer.
-
6 Ways to Help Teen Patients Navigate Loss
Know teens or young adults who have cancer? Here are some tips for helping them deal with grief.
-
Hodgkin Lymphoma: When Lightning Strikes Twice
Why are some families struck with multiple cases of Hodgkin lymphoma? Learn about the FAMHL clinical trial designed to pinpoint genetic causes.
-
Taking Aim at AML: The Mission Continues
Protein profiling may identify moving treatments targets for acute myeloid leukemia. Find out how researchers team up in the VENAML clinical trial to reduce cancer development.
-
When It Comes to Cancer, Children Aren’t Little Adults
New research proves that children and adults with cancer often have different mutated genes driving their diseases. This reinforces the need for pediatric-specific precision therapies.
-
SJFAMILY: Shaking the Family Tree
Through the SJFAMILY study, St. Jude investigators explore why some cancers run in families and why certain people get more than one cancer.
-
Researchers discover an Achilles heel in a lethal leukemia
Researchers have discovered how a linkage between two proteins in AML enables cancer cells to resist chemotherapy- disrupting the linkage could become a treatment pathway.
-
New pathway identified as a target for precision medicine against a common brain tumor
A newly identified component of the Sonic Hedgehog pathway offers another target for precision medicine for treatment of SHH medulloblastoma subtype
-
Flu vaccine failed to protect young leukemia patients during cancer treatment
The flu shot may not protect pediatric leukemia patients from influenza during cancer treatment, highlighting the need for additional safeguards.
-
Sperm banking is underutilized by adolescent and young adult cancer patients
Despite the fertility risk, most young male cancer patients don’t bank sperm before beginning cancer treatment.
-
Researchers discover how enzyme 'shape-shifts' in drug-resistant leukemia
New treatment strategies to overcome drug resistance in chronic myelogenous leukemia and other cancers will come from the detailed structure of the enzyme Abl.
-
St. Jude unveils powerful resource to advance treatment of pediatric solid tumors
Childhood Solid Tumor Network offers the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors
-
Leukemia and Lymphoma: The TOTAL Package
A new precision medicine study aims to push leukemia and lymphoma survival rates ever higher while reducing side effects.
-
A Plan Unfolds for Accelerating Progress
James R. Downing, MD, president and chief executive officer, is heading a six-year, $7 billion strategy to accelerate progress toward curing childhood cancer.
